Skip to content

Looking at blood phosphorus levels to predict how fast a patient recovers from Diabetic Ketoacidosis (DKA)

A Study on Serum Phosphorus Levels as a Prognostic Indicator in the Management of Diabetic Ketoacidosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105980
Enrollment
130
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R739- Hyperglycemia, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Jawaharlal Nehru Medical College and Associated Hospitals Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients who have given written informed consent 2)patients with diabetic keto acidosis 3)patients who are equal or more then 18yrs old

Exclusion criteria

Exclusion criteria: Patients who have not given written informed consent. Patients with malnutrition, malabsorption syndromes. Patients on diuretics, steroids, phosphate binding antacids. Patients with renal transplantation. Patients with hyperparathyroidism. Patients with pancreatitis, burns, volume expansion. Patients who are alcoholics. Respiratory alkalosis hyperventilation, panic attacks, salicylate poisoning Rapid cellular uptake refeeding syndrome, leukemic blast cell crises, hungry bone syndrome. Patients with Type 1 diabetes mellitus and other causes of ketoacidosis.

Design outcomes

Primary

MeasureTime frame
Association of serum phosphorus level with severity of diabetic ketoacidosis.Timepoint: Baseline (at admission), 24 hours after admission, and at discharge/final outcome.

Secondary

MeasureTime frame
Correlation between Serum Phosphorus and Serum Potassium levels during the first 24 hours of managementTimepoint: Measured at 0, 6, 12, and 24 hours.;Duration of Intensive Care Unit (ICU) stayTimepoint: From admission until ICU discharge.;Incidence of hypophosphatemia-related complications (e.g., muscle weakness, cardiac arrhythmias, or requirement for mechanical ventilation).Timepoint: From admission until hospital discharge.;Requirement for intravenous phosphate replacement therapy.Timepoint: During the first 48 hours of treatment.

Countries

India

Contacts

Public ContactDr BADRI PRASAD YADAV

Department of Emergency Medicine

Yadavbp15@gmail.com7737489197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026